Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company
By Margarita Michaels
01 October 2015
A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.